December 2015

Well-Controlled Bleeding with rVIII-SingleChain

July 11, 2016

Articles

Researchers reported that adults and adolescents with hemophilia A had well controlled bleeding when dosed two or three times weekly with recombinant factor VIII single chain (rVIII-SingleChain).

Two Grants Awarded to Medical College of Wisconsin Researcher

July 11, 2016

Articles

Researchers discovered a clinically translatable gene therapy protocol, which is a gene delivery system that introduced the production of therapeutic clotting proteins in platelets, so that the inhibition of inactivating antibodies is avoided.

FDA Approval Updates for Hemophilia Drugs

July 11, 2016

Articles

Over the past few months, the Food and Drug Administration (FDA) approved several drugs for the control and prevention of bleeding episodes in patients with hemophilia. Other drug classifications granted included Orphan Drug Status and Breakthrough Therapy designation.

Analysis of Hemophilia Studies Fit Guidelines and Recommendations

July 11, 2016

Articles

An analysis of randomized controlled trials (RCTs) published by the Institute for Quality and Efficiency in Health Care (IQWiG) determined that prophylactic treatment for hemophilia A is superior to on demand treatment in some outcomes.

x